Obtaining patent term extensions in Europe
IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
The second international American Diabetes Association/European Association for the Study of Diabetes report seeks to improve diabetes prevention and care with an individual focus.
Researchers are testing the effects of adding tucatinib to trastuzumab and pertuzumab maintenance in patients with HER2+ advanced breast cancer.
Thomas Callender and colleagues present a development and validation study using parsimonious ensemble machine learning models to assess eligibility for lung cancer screening.
In this Viewpoint, the authors summarize the therapeutic landscape for COVID-19, discuss who is most likely to benefit from treatment, provide an update on mana